Literature DB >> 24272352

Hypoxia and metabolism in cancer.

Karim Bensaad1, Adrian L Harris.   

Abstract

Interest in targeting metabolism has been renewed in recent years as research increases understanding of the altered metabolic profile of tumor cells compared with that of normal cells. Metabolic reprogramming allows cancer cells to survive and proliferate in the hostile tumor microenvironment. These metabolic changes support energy generation, anabolic processes, and the maintenance of redox potential, mechanisms that are all essential for the proliferation and survival of tumor cells. The metabolic switch in a number of key metabolic pathways is mainly regulated by genetic events, rendering cancer cells addicted to certain nutrients, such as glutamine. In addition, hypoxia is induced when highly proliferative tumor cells distance themselves from an oxygen supply. Hypoxia-inducible factor 1α is largely responsible for alterations in metabolism that support the survival of hypoxic tumor cells. Metabolic alterations and dependencies of cancer cells may be exploited to improve anticancer therapy. This chapter reviews the main aspects of altered metabolism in cancer cells, emphasizing recent advances in glucose, glutamine, and lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24272352     DOI: 10.1007/978-1-4614-5915-6_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  19 in total

Review 1.  The role of hypoxic signalling in metastasis: towards translating knowledge of basic biology into novel anti-tumour strategies.

Authors:  Joaquín Araos; Jonathan P Sleeman; Boyan K Garvalov
Journal:  Clin Exp Metastasis       Date:  2018-08-31       Impact factor: 5.150

2.  A pilot study of the effects of mild systemic heating on human head and neck tumour xenografts: Analysis of tumour perfusion, interstitial fluid pressure, hypoxia and efficacy of radiation therapy.

Authors:  Timothy B Winslow; Annu Eranki; Soumya Ullas; Anurag K Singh; Elizabeth A Repasky; Arindam Sen
Journal:  Int J Hyperthermia       Date:  2015-05-19       Impact factor: 3.914

3.  24-Hydroxycholesterol participates in pancreatic neuroendocrine tumor development.

Authors:  Matias Soncini; Gianfranca Corna; Marta Moresco; Nadia Coltella; Umberto Restuccia; Daniela Maggioni; Laura Raccosta; Chin-Yo Lin; Francesca Invernizzi; Roberto Crocchiolo; Claudio Doglioni; Catia Traversari; Angela Bachi; Rosa Bernardi; Claudio Bordignon; Jan-Åke Gustafsson; Vincenzo Russo
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

Review 4.  Plasma cell survival: The intrinsic drivers, migratory signals, and extrinsic regulators.

Authors:  Doan C Nguyen; Meixue Duan; Mohammad Ali; Ariel Ley; Ignacio Sanz; F Eun-Hyung Lee
Journal:  Immunol Rev       Date:  2021-08-01       Impact factor: 10.983

Review 5.  Metabolic and hypoxic adaptation to anti-angiogenic therapy: a target for induced essentiality.

Authors:  Alan McIntyre; Adrian L Harris
Journal:  EMBO Mol Med       Date:  2015-04       Impact factor: 12.137

6.  Preliminary Evidence That High-Dose Vitamin C has a Vascular Disrupting Action in Mice.

Authors:  Bruce C Baguley; Qi Ding; Emma Richardson
Journal:  Front Oncol       Date:  2014-11-05       Impact factor: 6.244

Review 7.  Hitting the Bull's-Eye in Metastatic Cancers-NSAIDs Elevate ROS in Mitochondria, Inducing Malignant Cell Death.

Authors:  Stephen John Ralph; Rhys Pritchard; Sara Rodríguez-Enríquez; Rafael Moreno-Sánchez; Raymond Keith Ralph
Journal:  Pharmaceuticals (Basel)       Date:  2015-02-13

8.  Upregulation of glycolysis and oxidative phosphorylation in benzo[α]pyrene and arsenic-induced rat lung epithelial transformed cells.

Authors:  Huachen Chen; Lai-Sheung Lee; Guanwu Li; Sai-Wah Tsao; Jen-Fu Chiu
Journal:  Oncotarget       Date:  2016-06-28

9.  Hypoxia Induces Production of L-2-Hydroxyglutarate.

Authors:  Andrew M Intlekofer; Raymond G Dematteo; Sriram Venneti; Lydia W S Finley; Chao Lu; Alexander R Judkins; Ariën S Rustenburg; Patrick B Grinaway; John D Chodera; Justin R Cross; Craig B Thompson
Journal:  Cell Metab       Date:  2015-07-23       Impact factor: 31.373

10.  Phage display library selection of a hypoxia-binding scFv antibody for liver cancer metabolic marker discovery.

Authors:  Jing Liu; Qing Zhang; Hang Chen; Zhihui Gao; Yao Li; Zhongyuan Sun; Rong Xiang; Sihe Zhang
Journal:  Oncotarget       Date:  2016-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.